Unleashing the Immune System to Defeat Cancer



A healthy immune system is potentially equipped to detect and eradicate cancer cells.  Unfortunately, established tumours can deploy a number of strategies to evade and defeat immune attack. We are targeting these inhibitory mechanisms and, at the same time, stimulating the immune system to enable a strong and effective reponse against the tumour.

The Company


FasT Biopharma Ltd was established in 2016 to address new targets in immuno-oncology (IO). We are funded by Alderley Park Ventures and we are based in Alderley Park and in Oxford.  Our lead product is an optimised antibody against a key IO target